Latest Helicobacter pylori Stories
Administration of Helicobacter pylori DNA reduces symptoms, new research reveals pathway for future treatments ANN ARBOR, Mich., May 5, 2011 /PRNewswire-USNewswire/ -- DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice, according to a new study by University of Michigan Medical School scientists. The study published in Gut this month was performed by a team of investigators assembled by senior author John Y.
A potential vaccine against bacteria that cause serious gastric disorders including stomach cancer may be a step closer following a pioneering study by a University of Guelph chemist.
NEW YORK, April 6, 2011/PRNewswire/ -- Empire BlueCross BlueShield today announced an initiative to inform and educate physicians and consumers about important findings from the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG) related to a little known but common infection that is a precursor to serious stomach ailments.
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori (H. pylori) had significantly lower levels of iron compared to children who had the infection eradicated.
A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island (URI) and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori (H. pylori) -- a known cause of gastritis, ulcer disease and cancer.
Activating the right immune cells in infants could lead to new vaccine.
Activating the right immune cells in infants could lead to new vaccine strategies BOSTON, Dec.
YANG Nan, MAO ZongWan and SUN HongZhe et al., at the Department of Chemistry, University of Hong Kong and Sun Yat-sen University have characterized a series of bismuth citrate complexes by X-ray crystallography and modeled the structure of ranitidine bismuth citrate, a medicine used widely for the treatment of peptic ulcer and gastric reflux disease.
Helicobacter pylori, a common stomach bacterium, reduced the severity of inflammation of the colon caused by Salmonella in mice.
Researchers have discovered a mechanism by which Helicobacter pylori, the only known cancer-causing bacterium, disables a tumor suppressor protein in host cells.
Helicobacter pylori is a Gram-negative, microaerophilic bacterium that can inhabit various areas of the stomach, particularly the antrum. It causes low-level inflammation of the stomach lining and is linked to gastric ulcers and stomach cancer. Out of those infected, 80%, are asymptomatic. It was initially named Campyloacter pyloridis and then renamed C. pylori to correct the Latin grammar error. It was later placed in the genus, Helicobacter. Over 50% of the population has H. pylori in...
- An imitative word; an onomatopoetic word.